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Diabetes is on the increase worldwide, 
due mainly to the rise in the number of 
people with type 2 diabetes. Type 2 
diabetes is becoming more common 
because:
•	People are living longer, and diabetes is 
more prevalent in older people.
•	As people increasingly migrate to urban 
areas, exercise less, eat more, and eat 
less healthy food, more people are 
becoming obese – a primary cause of 
type 2 diabetes.
Diabetes increases the risk of a range of 
eye diseases, including cataract, but the 
main cause of blindness associated with 
diabetes is diabetic retinopathy (DR). DR 
usually develops between ten and twenty 
years after the onset of diabetes, and 
develops faster when diabetes is undiag-
nosed and untreated. 
People with DR whose sight is at risk 
can be treated, most commonly with 
laser, to prevent visual impairment and 
blindness. Sadly, there is no treatment 
that can restore vision that has already 
been lost. 
In 2030, the number of people with 
diabetes is expected to increase to 
440 million, 54% more than in 2010. 
This means that, for every two people 
with diabetes today, there would be three 
in 2030. But there will be a far greater 
increase in some of the world’s poorest 
regions (Table 1, overleaf). In sub-Saharan 
Africa, for example, the expected increase 
is 98%, which means the number of 
people with diabetes there would double.
As the prevalence of diabetes increases, 
so will the risk of DR. In 2002, the global 
average risk of blindness from DR 
amongst people with diabetes was calcu-
lated as 0.75% – meaning that, out of 
every 133 people with diabetes, one 
person will go blind. If we simply apply this 
statistic to the expected number of 
people predicted to have diabetes in 
2030 (440 million), the number of 
people likely to go blind from DR would 
be 3.3 million.
In the poorest regions, however, the 
average risk of blindness from DR tends 
to be higher than 1 in 133. An important 
reason for this is that the infrastructure 
and resources required to effectively 
address DR are either inadequate or 
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 Journal absent. For example, in one recent survey 
in Central America, 1.2% of people with 
diabetes were blind from DR (around 
1 in 84).
In this respect, the current projections 
of the future global increase in blindness 
from DR appear optimistic, and the 
number people likely to become blind as a 
result of DR in 2030 could be much 
higher than 3.3 million. 
Fortunately, because of the ten- to 
twenty-year delay in the onset of DR, we 
still have a small window of opportunity to 
put systems, equipment, 
and people in place now 
to cope with, and 
wherever possible 
prevent, the epidemic of 
DR that is likely to affect 
the poorest countries a 
decade or so from now.
What	can	we	do?	
Many readers of this 
journal are ophthalmic nurses or medical 
assistants, and some may feel that DR is 
a complicated problem which should be 
left to programme managers or ophthal-
mologists to address. However, there is a 
great deal that all eye care workers and 
their health care colleagues can do to 
address DR, by supporting each of the 
following:     
•	prevention of diabetes
•	early diagnosis of diabetes
•	good control of blood sugar and blood 
pressure amongst people with diabetes
•	early diagnosis of DR
•	referral for treatment. 
Prevention of diabetes. At the primary 
care level, we can emphasise the impor-
tance of a healthy diet and exercise, since 
much of the increase in diabetes is a 
result of increasing obesity. Eye workers 
should join with other health workers to 
emphasise that diabetes 
– and diabetic retinopathy 
– can be avoided by making 
healthier lifestyle choices. 
Early diagnosis of 
diabetes. The people 
who are blind from DR 
today are the same 
people whose diabetes 
was undiagnosed or 
poorly controlled ten years 
ago. We know that early diagnosis of 
diabetes followed by good control of blood 
sugar and blood pressure will reduce the 
incidence of DR (page 4). However, many 
people do not know they have diabetes: the 
recent Nigeria national blindness and 
visual impairment survey found that nearly 
half of all participants with high blood 
sugar did not know they had diabetes. 
‘Diabetes – and 
diabetic retinopathy 
– can be avoided by 
making healthier 
lifestyle choices’
Table 1. Expected increase in number of people with diabetes: 2010–2030
Courtesy of Zoe Okrim. Data taken from IDF Diabetes Atlas 4th Ed, © International Diabetes Federation 2009
2010 2030
number 
of 
people 
with 
diabetes
Prevalence 
of 
diabetes
number of 
people 
with 
diabetes
Prevalence 
of 
diabetes
increase 
in number 
of people 
with 
diabetes
region millions % millions % %
Europe 55.2 6.9 66.2 8.1 20.0
North America 
and Caribbean
37.4 10.2 53.2 12.1 42.4
Middle East and 
North Africa
26.6 9.3 51.7 10.8 93.9
South and 
Central America
18 6.6 29.6 7.8 65.1
Western Pacific 
(incl. China)
76.7 4.7 112.8 5.7 47.0
Southeast Asia 
(incl. India)
58.7 7.6 101 9.1 72.1
Sub-Saharan 
Africa
12.1 3.8 23.9 4.7 98.1
total (average) 284.6 (6.4) 438.4 (7.7) 54.0
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manage diabetes and its complications, 
we must therefore do more to look for 
people with diabetes and improve their 
care (page 16). One example would be to 
do routine urine or blood glucose testing 
on all patients who present with cataract. 
Good control of blood sugar and blood 
pressure. Even though improving a 
patient’s control of blood sugar and blood 
pressure may be outside our area of 
expertise, we can advise our patients 
about the importance of good control and 
support them by ensuring that we are 
working in partnership with physicians 
and diabetes specialists. We should use 
every opportunity to reinforce the 
message that good control in the present 
will pay off in the future. 
Early diagnosis of Dr. Where there is 
treatment available for DR, all health care 
workers must reinforce the following 
messages when working with diabetes 
patients: 
•	Diabetes can cause blindness
•	The early stages are only detectable by 
examination of the retina
•	Everyone with diabetes should have an 
annual retinal examination to allow early 
diagnosis and treatment.
If all of us used every contact with every 
diabetes patient to reinforce these 
messages, then we can be confident that 
there would be a reduction in the risk of 
blindness due to DR. 
referral for treatment. For ophthalmol-
ogists and health planners, there is an 
urgent need to ensure that networks and 
resources for the referral and treatment of 
DR are in place. It is impossible and 
unnecessary to provide a laser in every 
eye clinic. However, every eye clinic needs 
to know where to send their patients who 
need laser treatment. Ophthalmology 
residency programmes should ensure 
that their curricula emphasise the condi-
tions that will be the major causes of 
blindness in the future, such as DR. 
Although not all ophthalmologists will treat 
DR, they must all know how to recognise 
it and when to refer patients for treatment. 
Thinking	beyond	the	clinic
One of the challenges in managing DR is 
that it requires partnerships with many 
different health care workers – both to 
find people with diabetes and to provide 
the eye care they need. We have to forge 
alliances with physicians, podiatrists, 
dieticians, pharmacists and all the other 
health workers and policy makers involved 
in the care of patients with diabetes. We 
will depend on them to encourage their 
patients to have annual eye examinations 
and we must return the favour by encour-
aging the patients we see to maintain 
good control of their diabetes and blood 
pressure. Every eye health worker can 
play a part in reaching out to other health 
workers and building the networks that 
will be critically important for preventing 
blindness from DR. 
In this issue we have tried to make the 
complexities of DR relatively simple, so 
that all eye health workers will have a 
clearer idea of what DR is and what it 
looks like. We hope that the relatively 
simple DR grading system on page 12 will 
help you to decide who has sight-threat-
ening DR and who has not. We have also 
tried to give clear guidelines for 
management, based on the best 
available evidence (page 5). 
There is no single solution to DR that 
can be applied to every community 
worldwide. As with VISION 2020, the best 
results will be achieved by developing 
programmes at district level that take into 
account local conditions and resources. 
We have included some guidelines and a 
case study of a diabetes programme 
(page 17), not as a blueprint to be 
followed in every detail, but to help you to 
think about how you might achieve the 
same things in your own district, clinic, 
or village. 
If there is one single message in this 
issue of the journal, it is this: diabetes 
and DR are everybody’s business. We 
must not leave it just to the specialists, 
whether they are specialists in diabetes or 
in retinal disease. In future, every single 
health worker will have to contribute to 
preventing, detecting, and managing 
diabetes and diabetic retinopathy. 
Blood sugar levels are controlled by 
insulin, a hormone secreted by cells in 
the pancreas. In diabetes, this control 
mechanism breaks down, which leads 
to high levels of glucose in the blood. 
Type 1 diabetes is uncommon. It is 
caused by destruction of the insulin-
secreting cells in the pancreas, and at 
present there is no means of predicting 
or preventing it. It occurs in young 
people and begins suddenly. This type of 
diabetes always requires treatment with 
injections of insulin. 
Type 2 diabetes is much more 
common. It begins very gradually and 
may be completely without symptoms. 
Until recently, it was thought to affect 
only people over 40 years old, but it is 
now found in much younger patients, 
particularly in association with obesity. 
In most people, type 2 diabetes is 
related to obesity and may be prevented 
and often controlled by weight loss and 
exercise. Not all people with type 2 
diabetes will require insulin. Some may 
be treated with tablets and some may 
only require weight loss to restore 
control of blood sugar. 
Both type 1 and type 2 diabetes are 
serious conditions. In both forms, the 
elevated blood sugar causes complica-
tions, most of which are due to damage 
to small blood vessels. This causes 
diabetic retinopathy, kidney disease, 
and foot ulceration – which may lead to 
amputation. In addition, the high blood 
sugar increases the risk of blockage of 
larger blood vessels, leading to strokes 
and heart attacks. 
In diabetic retinopathy (Dr), 
damaged small blood vessels leak in the 
retina at the back of the eye. Later, the 
blood vessels become blocked, which 
leads to the formation of abnormal new 
blood vessels. These new vessels are 
fragile and can bleed into the vitreous 
gel; they can also pull on the retina, 
causing retinal detachment. If blood 
vessels become damaged in the central 
part of the retina, this causes diabetic 
maculopathy, which is characterised by 
swelling of the retina (macular oedema). 
All of these changes can damage 
vision permanently, and eventually lead 
to blindness unless the patient receives 
treatment (mainly laser treatment). 
Even then, treatment will only stop or 
slow down the disease – existing 
damage to the eye or to the patient’s 
vision cannot be undone.
Everyone with diabetes will develop 
some degree of DR eventually, most 
commonly after ten or more years of 
living with diabetes. High blood sugar 
and high blood pressure increases the 
risk of developing DR.
Understanding diabetes and diabetic retinopathy
all diabetes patients must have a retinal 
examination every year. ParaGuay
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